The known benefits of statin therapy in preventing cardiovascular disease, including heart attacks and strokes, outweigh the slightly increased risk of muscle symptoms, according to late […]
Monoclonal antibodies are laboratory-designed treatments tailor-made to fight specific infections. In early 2021, the U.S. Food & Drug Administration issued emergency use authorization for two monoclonal […]
A phase 2 trial in patients with a prior ischemic stroke or high-risk transient ischemic attack (TIA) has indicated that milvexian should be further investigated for […]